There are 248 resources available
78P - A systematic review and meta-analysis of trials assessing activity of PD-1/PD-L1 immune checkpoint inhibitors (ICIs) for pre-treated advanced malignant mesothelioma (aMM)
Presenter: Marco Tagliamento
Session: Lunch & Poster Display session
Resources:
Abstract
79P - Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
Presenter: Takatoshi Enomoto
Session: Lunch & Poster Display session
Resources:
Abstract
80P - Nintedanib (N) + docetaxel (D) after immunotherapy in adenocarcinoma non-small cell lung cancer (NSCLC): First results from the non-interventional LUME-BioNIS study
Presenter: Martin Reck
Session: Lunch & Poster Display session
Resources:
Abstract
81P - Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX , a retrospective multicentric study: Preliminary data
Presenter: Solène Valery
Session: Lunch & Poster Display session
Resources:
Abstract
82P - Real-world survival with first-line (1L) chemotherapy in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
Presenter: David Waterhouse
Session: Lunch & Poster Display session
Resources:
Abstract
83P - Analysis of predictive factors in non-small cell lung cancer patients treated with nivolumab
Presenter: Koji Azuma
Session: Lunch & Poster Display session
Resources:
Abstract
84P - Survival outcomes in stage IV small-cell lung cancer (IV-SCLC): Analysis from SEER database
Presenter: Javier de Castro Carpeño
Session: Lunch & Poster Display session
Resources:
Abstract
85P - Impact of digital patient monitoring (DPM) on quality of clinical care of cancer immunotherapy (CIT)-treated patients (pts) with advanced/metastatic non-small cell lung cancer (a/mNSCLC)
Presenter: Oliver Schmalz
Session: Lunch & Poster Display session
Resources:
Abstract
86P - A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC
Presenter: Giuseppe Viscardi
Session: Lunch & Poster Display session
Resources:
Abstract
87P - Clinical outcomes of metastasic melanoma patients treated with ipilimumab and nivolumab: A single institution experience
Presenter: HONEY KUMAR Oberoi Oberoi
Session: Lunch & Poster Display session
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.